Nifty
:
22378.80
Sensex
:
74002.35
-23.60 (-0.11%)
149.41 (0.20%)
Nifty
Sensex
:
:
22378.80
74002.35
-23.60 (-0.11%)
149.41 (0.20%)

Torrent Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Global

Rating :
68/99

BSE: 500420 | NSE: TORNTPHARM

NSE BSE
2686.45
24-Apr-2024
  • Open
  • High
  • Low
  • Previous Close
  •  2639.90
  •  2699.00
  •  2639.90
  •  2637.40
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  254562
  •  6807.84
  •  2744.00
  •  1598.45

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 90,872.60
  • 60.83
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 94,732.60
  • 0.82%
  • 12.71

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 71.25%
  • 0.38%
  • 4.08%
  • FII
  • DII
  • Others
  • 14.14%
  • 6.51%
  • 3.64%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.68
  • 4.63
  • 6.32

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.49
  • 7.40
  • 2.63

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.49
  • 23.34
  • -0.18

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 40.93
  • 52.83
  • 52.83

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.34
  • 8.29
  • 9.00

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.62
  • 20.72
  • 22.06

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Net Sales
2,732.00
2,491.00
9.67%
2,660.00
2,291.00
16.11%
2,591.00
2,347.00
10.40%
2,491.00
2,131.00
16.89%
Expenses
1,863.00
1,767.00
5.43%
1,835.00
1,612.00
13.83%
1,800.00
1,635.00
10.09%
1,764.00
1,570.00
12.36%
EBITDA
869.00
724.00
20.03%
825.00
679.00
21.50%
791.00
712.00
11.10%
727.00
561.00
29.59%
EBIDTM
31.81%
29.06%
31.02%
29.64%
30.53%
30.34%
29.19%
26.33%
Other Income
-33.00
-10.00
-
26.00
16.00
62.50%
34.00
30.00
13.33%
9.00
56.00
-83.93%
Interest
80.00
102.00
-21.57%
91.00
69.00
31.88%
103.00
55.00
87.27%
107.00
57.00
87.72%
Depreciation
213.00
193.00
10.36%
201.00
163.00
23.31%
191.00
155.00
23.23%
196.00
162.00
20.99%
PBT
631.00
419.00
50.60%
559.00
463.00
20.73%
531.00
532.00
-0.19%
433.00
-87.00
-
Tax
188.00
127.00
48.03%
173.00
151.00
14.57%
153.00
178.00
-14.04%
146.00
31.00
370.97%
PAT
443.00
292.00
51.71%
386.00
312.00
23.72%
378.00
354.00
6.78%
287.00
-118.00
-
PATM
16.22%
11.72%
14.51%
13.62%
14.59%
15.08%
11.52%
-5.54%
EPS
13.09
8.63
51.68%
11.40
9.22
23.64%
11.17
10.46
6.79%
8.48
-3.49
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
10,474.00
9,620.15
8,508.04
8,004.57
7,939.31
7,672.80
5,949.83
5,815.69
6,666.85
4,653.45
4,184.72
Net Sales Growth
13.11%
13.07%
6.29%
0.82%
3.47%
28.96%
2.31%
-12.77%
43.27%
11.20%
 
Cost Of Goods Sold
2,711.00
2,513.20
2,230.75
1,960.12
1,981.79
2,041.26
1,535.17
1,629.66
1,432.13
1,280.96
1,107.58
Gross Profit
7,763.00
7,106.95
6,277.29
6,044.45
5,957.52
5,631.54
4,414.66
4,186.03
5,234.72
3,372.49
3,077.14
GP Margin
74.12%
73.88%
73.78%
75.51%
75.04%
73.40%
74.20%
71.98%
78.52%
72.47%
73.53%
Total Expenditure
7,262.00
6,796.18
6,076.77
5,524.49
5,768.95
5,696.31
4,600.58
4,438.42
3,937.05
3,633.29
3,233.24
Power & Fuel Cost
-
155.28
144.19
122.94
128.19
132.46
118.77
107.98
92.59
97.41
71.88
% Of Sales
-
1.61%
1.69%
1.54%
1.61%
1.73%
2.00%
1.86%
1.39%
2.09%
1.72%
Employee Cost
-
1,677.69
1,526.45
1,439.62
1,429.04
1,403.79
1,135.25
993.41
842.35
841.81
741.10
% Of Sales
-
17.44%
17.94%
17.98%
18.00%
18.30%
19.08%
17.08%
12.63%
18.09%
17.71%
Manufacturing Exp.
-
570.79
591.13
550.92
544.11
558.84
457.58
502.16
353.45
345.98
320.78
% Of Sales
-
5.93%
6.95%
6.88%
6.85%
7.28%
7.69%
8.63%
5.30%
7.43%
7.67%
General & Admin Exp.
-
775.30
637.65
633.48
801.98
763.90
677.71
578.05
637.92
463.28
398.98
% Of Sales
-
8.06%
7.49%
7.91%
10.10%
9.96%
11.39%
9.94%
9.57%
9.96%
9.53%
Selling & Distn. Exp.
-
1,026.99
884.91
742.63
807.39
738.03
641.30
567.70
547.05
574.40
461.53
% Of Sales
-
10.68%
10.40%
9.28%
10.17%
9.62%
10.78%
9.76%
8.21%
12.34%
11.03%
Miscellaneous Exp.
-
76.93
61.69
74.78
76.45
58.03
34.80
59.46
31.56
29.45
461.53
% Of Sales
-
0.80%
0.73%
0.93%
0.96%
0.76%
0.58%
1.02%
0.47%
0.63%
3.14%
EBITDA
3,212.00
2,823.97
2,431.27
2,480.08
2,170.36
1,976.49
1,349.25
1,377.27
2,729.80
1,020.16
951.48
EBITDA Margin
30.67%
29.35%
28.58%
30.98%
27.34%
25.76%
22.68%
23.68%
40.95%
21.92%
22.74%
Other Income
36.00
63.22
196.56
56.91
121.30
63.62
298.84
223.30
228.80
285.55
38.13
Interest
381.00
333.44
255.06
352.94
450.71
503.75
308.48
205.56
183.98
175.16
58.63
Depreciation
801.00
706.59
662.16
657.79
654.38
617.69
408.60
306.92
237.55
190.74
87.00
PBT
2,154.00
1,847.16
1,710.61
1,526.26
1,186.57
918.67
931.01
1,088.09
2,537.07
939.81
843.98
Tax
660.00
601.93
448.73
274.38
161.85
125.35
252.87
154.51
610.17
188.84
180.07
Tax Rate
30.64%
32.59%
36.60%
17.98%
13.64%
22.32%
27.16%
14.20%
26.04%
20.09%
21.34%
PAT
1,494.00
1,245.23
777.18
1,251.88
1,024.72
436.28
678.11
933.55
1,733.24
750.94
663.88
PAT before Minority Interest
1,494.00
1,245.23
777.18
1,251.88
1,024.72
436.31
678.14
933.58
1,733.27
750.97
663.91
Minority Interest
0.00
0.00
0.00
0.00
0.00
-0.03
-0.03
-0.03
-0.03
-0.03
-0.03
PAT Margin
14.26%
12.94%
9.13%
15.64%
12.91%
5.69%
11.40%
16.05%
26.00%
16.14%
15.86%
PAT Growth
77.86%
60.22%
-37.92%
22.17%
134.88%
-35.66%
-27.36%
-46.14%
130.81%
13.11%
 
EPS
44.15
36.80
22.97
36.99
30.28
12.89
20.04
27.59
51.22
22.19
19.62

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
6,198.07
5,952.95
5,837.17
4,823.22
4,724.35
4,622.19
4,350.13
3,494.10
2,490.56
1,902.43
Share Capital
169.23
84.62
84.62
84.62
84.62
84.62
84.62
84.62
84.62
84.62
Total Reserves
6,028.84
5,868.33
5,752.55
4,738.60
4,639.73
4,537.57
4,265.51
3,409.48
2,405.94
1,817.81
Non-Current Liabilities
2,822.81
2,238.15
2,924.20
3,299.15
3,861.40
4,142.42
2,303.33
1,994.65
2,504.92
926.76
Secured Loans
2,496.22
2,123.22
2,941.07
3,302.29
3,909.81
4,105.31
2,229.57
1,839.46
2,171.60
730.72
Unsecured Loans
0.00
0.00
0.00
1.56
3.11
6.15
11.26
10.62
13.62
13.74
Long Term Provisions
393.06
368.74
369.62
338.34
288.52
286.66
263.04
246.36
207.49
190.43
Current Liabilities
5,447.30
4,415.09
4,891.62
5,454.16
5,165.32
5,202.17
2,738.26
3,285.48
2,823.75
2,174.58
Trade Payables
1,678.80
1,674.44
2,066.81
2,048.81
2,096.74
2,048.24
1,749.32
2,260.22
1,827.72
1,429.13
Other Current Liabilities
1,578.41
1,365.10
1,635.36
1,860.80
1,641.26
1,151.68
687.14
822.28
446.15
371.63
Short Term Borrowings
1,765.07
923.04
704.40
1,090.85
934.11
1,625.60
0.00
3.32
319.07
210.43
Short Term Provisions
425.02
452.51
485.05
453.70
493.21
376.65
301.80
199.66
230.81
163.39
Total Liabilities
14,468.18
12,606.19
13,652.99
13,576.53
13,751.07
13,967.30
9,392.21
8,774.69
7,819.66
5,004.17
Net Block
8,121.45
6,422.65
7,064.63
7,533.12
7,747.71
7,854.68
3,688.44
2,859.08
2,832.66
875.34
Gross Block
12,811.62
10,728.19
10,511.53
10,334.13
9,935.43
9,449.48
4,909.80
3,793.53
3,542.93
1,420.04
Accumulated Depreciation
4,690.17
4,305.54
3,446.90
2,801.01
2,187.72
1,594.80
1,221.36
934.45
710.27
544.70
Non Current Assets
9,139.00
7,311.54
8,129.77
8,595.61
8,713.53
8,704.89
4,512.74
4,085.66
3,768.25
1,599.69
Capital Work in Progress
765.40
629.82
889.38
711.93
617.12
646.94
519.49
1,041.58
678.33
534.11
Non Current Investment
42.70
42.33
42.09
2.09
2.09
0.09
0.09
0.09
0.06
0.03
Long Term Loans & Adv.
181.04
166.55
96.84
222.19
150.58
130.96
182.32
99.66
206.92
129.47
Other Non Current Assets
28.41
50.19
36.83
126.28
196.03
72.22
122.40
85.25
50.28
60.74
Current Assets
5,313.72
5,164.99
5,523.22
4,980.92
5,037.54
5,262.41
4,879.47
4,689.03
4,051.41
3,404.48
Current Investments
156.09
183.98
139.05
0.02
351.35
492.27
803.55
779.59
297.59
185.63
Inventories
2,229.64
2,462.32
2,681.20
2,148.22
1,935.15
1,966.30
1,559.15
1,357.98
1,067.17
1,006.06
Sundry Debtors
1,943.82
1,632.48
1,523.37
1,649.34
1,435.71
1,253.45
950.89
1,445.09
1,587.26
1,099.42
Cash & Bank
571.46
403.41
603.50
666.65
816.04
867.23
893.72
647.03
567.36
769.42
Other Current Assets
412.71
331.62
512.69
443.21
499.29
683.16
672.16
459.34
532.03
343.95
Short Term Loans & Adv.
165.82
151.18
63.41
73.48
93.46
95.39
82.62
90.18
109.09
84.95
Net Current Assets
-133.58
749.90
631.60
-473.24
-127.78
60.24
2,141.21
1,403.55
1,227.66
1,229.90
Total Assets
14,452.72
12,476.53
13,652.99
13,576.53
13,751.07
13,967.30
9,392.21
8,774.69
7,819.66
5,004.17

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Cash From Operating Activity
2,368.13
1,802.99
2,005.35
1,392.91
1,798.08
894.15
1,008.84
2,742.12
810.20
599.42
PBT
1,847.16
1,225.91
1,526.26
1,186.57
561.66
931.01
1,088.09
2,343.44
939.81
843.98
Adjustment
937.24
1,349.95
992.84
876.21
1,418.19
606.92
430.27
552.44
337.96
136.79
Changes in Working Capital
-18.20
-351.85
-338.25
-385.83
99.39
-360.16
-125.21
423.58
-409.38
-119.68
Cash after chg. in Working capital
2,766.20
2,224.01
2,180.85
1,676.95
2,079.24
1,177.77
1,393.15
3,319.46
868.39
861.09
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-398.07
-421.02
-175.50
-284.04
-281.16
-283.62
-384.31
-577.34
-58.19
-261.67
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-2,415.31
-196.63
-449.42
198.61
-241.28
-4,706.95
-786.91
-837.85
-2,162.30
-355.81
Net Fixed Assets
-2,494.94
-29.00
-198.83
-378.80
-610.74
-4,245.22
-592.01
-471.42
-2,266.57
-308.01
Net Investments
6.43
-53.72
-179.03
351.33
138.83
310.79
-17.69
-484.32
-111.97
-131.60
Others
73.20
-113.91
-71.56
226.08
230.63
-772.52
-177.21
117.89
216.24
83.80
Cash from Financing Activity
77.36
-1,781.05
-1,650.79
-1,549.04
-1,314.45
3,417.39
-192.91
-1,435.15
1,212.25
86.40
Net Cash Inflow / Outflow
30.18
-174.69
-94.86
42.48
242.35
-395.41
29.02
469.12
-139.85
330.01
Opening Cash & Equivalents
398.40
572.56
661.82
588.76
702.04
1,067.57
1,049.86
612.38
955.05
687.41
Closing Cash & Equivalent
508.53
398.40
572.56
661.82
940.06
702.04
1,067.57
1,049.86
864.95
955.05

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
183.13
175.87
172.45
284.99
279.15
273.11
257.04
206.46
147.16
112.41
ROA
9.20%
5.92%
9.20%
7.50%
3.15%
5.81%
10.28%
20.89%
11.71%
15.16%
ROE
20.50%
13.18%
23.49%
21.47%
9.34%
15.12%
23.80%
57.92%
34.19%
39.94%
ROCE
20.32%
14.35%
17.62%
15.28%
9.75%
13.81%
20.36%
45.63%
26.98%
35.06%
Fixed Asset Turnover
1.39
1.43
1.43
1.48
1.50
1.57
1.35
1.82
1.88
3.11
Receivable days
39.91
37.86
38.92
37.65
33.78
35.74
74.66
82.76
105.19
77.81
Inventory Days
52.36
61.71
59.24
49.84
49.01
57.16
90.90
66.19
81.17
84.02
Payable days
243.50
306.08
383.19
133.47
139.05
150.99
171.27
204.35
176.11
158.58
Cash Conversion Cycle
-151.22
-206.50
-285.04
-45.98
-56.26
-58.09
-5.72
-55.41
10.25
3.25
Total Debt/Equity
0.85
0.68
0.83
1.21
1.28
1.40
0.58
0.67
1.10
0.59
Interest Cover
6.54
5.81
5.32
3.63
2.11
4.02
6.29
13.74
6.37
15.40

Annual Reports:

FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014

News Update:


  • USFDA issues EIR to Torrent Pharmaceuticals’ Gujarat facility
    6th Mar 2024, 10:13 AM

    USFDA has now successfully concluded inspection at Torrent Pharmaceuticals’ Oral-Oncology manufacturing facility

    Read More
  • Torrent Pharmaceuticals reports 52% rise in Q3 consolidated net profit
    3rd Feb 2024, 14:36 PM

    Total consolidated income of the company increased by 8.79% at Rs 2699 crore for Q3FY24

    Read More
  • Torrent Pharma - Quarterly Results
    2nd Feb 2024, 13:53 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.